AstraZeneca's asthma drug fails in study

May 10 (Reuters) - Drugmaker AstraZeneca Plc said its asthma drug failed to meet the main goal of significantly reducing the annual asthma exacerbation rate in a late-stage study.

by reutersCOMPANYNEWS via Endless Supplies .Biz - News